(13aR,13bR)-4,4-dimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione (74612-20-7)

Identification
Name:	(13aR,13bR)-4,4-dimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
CAS:	74612-20-7
Molecular Formula:	C₁₅H₂₁NO₄
Molecular Weight:	279.3315
InChI:	InChI=1/C15H21NO4/c1-15(2)7-12(17)19-9-10-3-5-16-6-4-11(14(10)16)20-13(18)8-15/h3,11,14H,4-9H2,1-2H3/t11-,14-/m1/s1
Molecular Structure:
Properties
Flash Point:	259°C
Boiling Point:	504.6°C at 760 mmHg
Density:	1.22g/cm³
Refractive index:	1.551
Flash Point:	259°C
Safety Data

Other Product

(3R,4R,5R,13aR,13bR)-4,5-dihydroxy-5-[(1R)-1-hydroxyethyl]-3-(propan-2-yl)-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,4,5,8,10,12,13,13a,13b-octahydro-4-hydroxy-3,4,5-trimethyl-,(3R,4S,5S,13aR,13bR)- (9CI)
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,5-ethyl-4,5,8,10,12,13,13a,13b-octahydro-4,5-dihydroxy-3-(1-methylethyl)-,(3R,4R,5R,13aR,13bR)- (9CI)
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,5-ethyl-4,5,8,10,12,13,13a,13b-octahydro-4,5-dihydroxy-3-(1-methylethyl)-,(5R,13aR,13bR)- (9CI)
8H,11H-Oxeto[2',3':9,10][1,6]dioxacycloundecino- [2,3,4-gh]pyrrolizine-8,12(9H)-dione,1,2,4,6,- 9a,11a,13a,13b-octahydro-,(9R,9aR,11aR,- 13aR,13bR)-
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine- 2,6(3H)-dione,4,5,8,10,12,13,13a,13boctahydro- 4,5-dihydroxy-5-(hydroxymethyl)- 4-methyl-3-(1-methylethyl)-,(3R,4R,5R,- 13aR,13bR)-
4-hydroxy-3,4,5-trimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,decahydro-4-hydroxy-3,4,5-trimethyl-, (8aR,13aR,13bR)- (9CI)
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,4,5,8,10,12,13,13a,13b-octahydro-5-hydroxy-3,4,5-trimethyl-,(3R,4S,5R,13aR,13bR)- (9CI)
(3R,4R,5R,13aR,13bR)-4,5-dihydroxy-3,4,5-trimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione hydrochloride (1:1)
Butanoic acid,2-methyl-,(3R,4S,5R,13aR,13bR)-3,4,5,6,8,10,12,13,13a,13b-decahydro-5-hydroxy-3,4,5-trimethyl-2,6-dioxo-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizin-4-ylester, (2R)- (9CI)
4,5-dihydroxy-5-methyl-3-(propan-2-yl)-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
4-hydroxy-3,4,5-trimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione 11-oxide
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,4,5,8,10,12,13,13a,13b-octahydro-4,5-dihydroxy-3,4,5-trimethyl-,(3R,4R,5R,13aR,13bR)-
5-(1-hydroxyethyl)-3,4-dimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
(3R,4S,5R,8aR,13aR,13bR)-5-hydroxy-3,4,5-trimethyldecahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
4-hydroxy-3,4,5-trimethyldecahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine- 2,6(3H)-dione,4,5,8,10,12,13,13a,13boctahydro- 4-hydroxy-3,4,5-trimethyl-
1H,5H,10H-Dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one,2,3,6,7,7a,8,13,13a,13b,13c-decahydro-, 4-oxide, (4R,7aS,13aR,13bR,13cS)-
1/C11H10O2/c1-9(12)3-4-10-5-7-11(13-2)8-6-10/h5-8H,1-2H